MJoTAtalks

Dr Susanna's guide to

www.MJoTA.org
click here

www.MJoTAtalks.org click here

www.drsusanna.org click here



Dr Susanna loves the countries and the peoples of Africa
 
Bookmark and Share
Diabetes news from the American Diabetes Association

Latest Top (20) News
Diabetes News
Diabetes news from the National Institutes of Health Diabetes Educators.

Latest Top (10) News
Clinical trials testing therapies for diabetes

Latest Top (10) News


A Pilot Study of Small Fiber Neuropathy Prevalence in Fibromyalgia Patients Compared to Healthy Subjects Using Sudoscan®
Condition:   Fibromyalgia
Intervention:   Device: Sudoscan®
Sponsor:   University Hospital, Clermont-Ferrand
Not yet recruiting

Mon, 20 Nov 2017 12:00:00 EST


Reward Mechanisms in Obesity
Condition:   Obesity
Intervention:   Drug: Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml or Placebo
Sponsors:   Zoltan Pataky;   University of Geneva, Switzerland
Not yet recruiting

Mon, 20 Nov 2017 12:00:00 EST


Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382
Condition:   Healthy Volunteers
Interventions:   Biological: MEDI0382;   Drug: Warfarin;   Drug: Esmolol
Sponsor:   MedImmune LLC
Not yet recruiting

Mon, 20 Nov 2017 12:00:00 EST


Vitamin D and Immune Mechanisms of Hypertension in Type 2 Diabetics
Conditions:   Diabetes Mellitus, Type 2;   Hypertension;   Vitamin D Deficiency
Intervention:   Diagnostic Test: Blood draw
Sponsor:   Washington University School of Medicine
Recruiting

Mon, 20 Nov 2017 12:00:00 EST


Anthropometric Parameters, Metabolic Profile and Function of the Respiratory System in Obese Patients
Conditions:   Obesity;   Diet Modification;   Physical Activity
Intervention:   Behavioral: diet and physical activity
Sponsor:   Poznan University of Medical Sciences
Recruiting

Fri, 17 Nov 2017 12:00:00 EST


Assessment of Color Vision in Diabetic Patients
Condition:   Retinopathy, Diabetic
Intervention:   Drug: lucentis
Sponsor:   Instituto de Olhos de Goiania
Completed

Fri, 17 Nov 2017 12:00:00 EST


Evolution of Total Energy Expenditure and Its Various Components in Active Rheumatoid Arthritis (RA)Treated With Anti-TNF Agents and Comparison With Healthy Subjects
Condition:   Active Rheumatoid Arthritis
Intervention:   Behavioral: Energy metabolism of patients suffering from RA
Sponsors:   University Hospital, Clermont-Ferrand;   Centre de Recherche en Nutrition Humaine d'Auvergne
Not yet recruiting

Fri, 17 Nov 2017 12:00:00 EST


PROMINENT-Eye Ancillary Study (Protocol AD)
Conditions:   Diabetic Retinopathy;   Diabetic Macular Edema
Interventions:   Drug: Pemafibrate;   Drug: Placebo
Sponsors:   Jaeb Center for Health Research;   Kowa Company, Ltd.
Not yet recruiting

Fri, 17 Nov 2017 12:00:00 EST


A Phase IV Study to Assess the Efficacy and Safety of Dapagliflozin Compared With Acarbose in Drug-Naive Patients With T2DM in China
Condition:   Type 2 Diabetes Mellitus
Intervention:   Drug: Dapagliflozin/Acarbose
Sponsor:   AstraZeneca
Not yet recruiting

Thu, 16 Nov 2017 12:00:00 EST


Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes
Condition:   Type2 Diabetes
Interventions:   Drug: Alirocumab;   Other: Placebo
Sponsors:   Nantes University Hospital;   Regeneron Pharmaceuticals
Not yet recruiting

Thu, 16 Nov 2017 12:00:00 EST
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA approves first telehealth option to program cochlear implants remotely
FDA approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.

Fri, 17 Nov 2017 14:45:00 -0500


Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls
Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts by the agency to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

Fri, 17 Nov 2017 09:03:00 -0500


FDA expands approval of Sutent to reduce the risk of kidney cancer returning
FDA approves first adjuvant treatment for adult patients who are at a high risk of kidney cancer returning after a kidney has been removed.

Thu, 16 Nov 2017 15:35:00 -0500


FDA approves new treatment to prevent bleeding in certain patients with hemophilia A
FDA approves new treatment to prevent or reduce frequency of bleeding episodes in patients with hemophilia A who have Factor VIII inhibitors.

Thu, 16 Nov 2017 11:26:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health
Commissioner statement on FDA’s comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy

Thu, 16 Nov 2017 09:23:00 -0500


FDA announces comprehensive regenerative medicine policy framework
FDA announces comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy.

Thu, 16 Nov 2017 09:22:00 -0500


FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action
Newly authorized test detects genetic cancer mutations in 468 unique genes

Wed, 15 Nov 2017 13:16:00 -0500


FDA approves treatment for rare genetic enzyme disorder
FDA approves treatment for rare genetic enzyme disorder

Wed, 15 Nov 2017 12:10:00 -0500


FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal
FDA permits marketing of the first device for use in helping to reduce the symptoms of opioid withdrawal

Wed, 15 Nov 2017 11:17:00 -0500


FDA warns about illegal use of injectable silicone for body contouring and associated health risks
FDA issues safety communication about illegal use of injectable silicone for body contouring and associated health risks

Tue, 14 Nov 2017 09:59:00 -0500